UK-based big pharma GlaxoSmithKline (GSK) has released its Q2 2025 results, which highlight the varying successes of its ...

GSK plc GSK reported second-quarter 2025 core earnings of $1.23 per American depositary share (ADS), which beat the Zacks ...

CEO Emma Walmsley maintained that continued investment in the U.S. is a priority for the pharma to ensure its medicines for ...

GlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.

Wealthy Chinese consumers are likely to spend three times more than their peers on post-retirement healthcare over the next ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage company developing broad-spectrum antivirals using host-mimetic nanomedicine technology, ...

Scientists demonstrate dental floss can effectively deliver flu, protein and mRNA vaccines without needles by targeting ...

There have been lots of changes to COVID vaccine recommendations. Here is the current vaccine schedule for people 6 months to 65+ years old.

The good news is that the shingles vaccine is highly effective. The Centers for Disease Control and Prevention recommends that adults 50 and older get the two-shot regimen, two to six months apart, ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...